Abstract

Standard clinical practice dictates that all breast lumps require complete triple assessment. This comprises clinical examination, imaging with ultrasound (and mammography if over 35 years) and a tissue diagnosis, using either cytology or histology. This dictat is challenged in a well-written paper published in this issue of the Journal.1 The authors question whether biopsy is always necessary in a subgroup of patients at very low absolute risk of breast cancer. The paper refers to a small subgroup of women presenting to the breast clinic who are under the age of 25 years and have a clinically benign palpable lump.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.